The Democrats’ campaign fundraising platform hauled in record cash while raising troubling questions about foreign donations.
Speaker Mike Johnson is calling for expanded House probes into ActBlue, the Democrats’ behemoth fundraising platform, amid new concerns about foreign funding in U.S. elections.
Rep. Bryan Steil, chairman of the House Administration Committee, this week announced the findings from documents the committee obtained through a subpoena of ActBlue issued days before last month’s election. The records revealed that the fundraising platform continued to accept donations using “foreign prepaid/gift cards” into July, when Democrats and Vice President Kamala Harris’ presidential campaign reported record-shattering donation figures.
“ActBlue was accepting foreign gift cards until September. This is ILLEGAL,” the speaker wrote Wednesday on his X account. The Louisiana Republican assured Steil’s committee would “continue this important investigation into ActBlue next Congress.”
“Our work here is just getting started,” Johnson added. […]
— Read More: thefederalist.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.